Back to top
more

UnitedHealth Group (UNH)

(Delayed Data from NYSE)

$589.14 USD

589.14
2,548,638

-5.18 (-0.87%)

Updated Sep 16, 2024 04:00 PM ET

After-Market: $589.50 +0.36 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (211 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

Wall Street Kicks Off Q2 2023 Earnings Season

by Zacks Equity Research

Wall Street Kicks Off Q2 2023 Earnings Season

Mark Vickery headshot

JPMorgan Posts +20% Beat; C, WFC, UNH Also Outperform

by Mark Vickery

Earnings of $4.37 per share easily outpaced the $3.62 in the Zacks consensus and the $2.76 per share reported a year ago.

UnitedHealth (UNH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for UnitedHealth (UNH) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

UnitedHealth Group (UNH) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

UnitedHealth (UNH) delivered earnings and revenue surprises of 3.72% and 2.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Highlights Visa, UnitedHealth Group, Eli Lilly, Costco, Wholesale and Advanced Micro Devices

by Zacks Equity Research

Visa, UnitedHealth Group, Eli Lilly, Costco, Wholesale and Advanced Micro Devices are part of the Zacks top Analyst Blog .

Sheraz Mian headshot

Top Analyst Reports for Visa, UnitedHealth & Eli Lilly

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), UnitedHealth Group Incorporated (UNH) and Eli Lilly and Company (LLY).

Will UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q2 Earnings?

by Zacks Equity Research

UnitedHealth's (UNH) second-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues, as well as the number of people served.

Should You Invest in the Vanguard Health Care ETF (VHT)?

by Zacks Equity Research

Sector ETF report for VHT

Will High Medical Costs Affect UnitedHealth (UNH) Q2 Earnings?

by Zacks Equity Research

UnitedHealth's (UNH) second-quarter results are likely to reflect growth in memberships and expense levels.

Factors That Make Universal Health (UHS) an Attractive Bet Now

by Zacks Equity Research

Universal Health (UHS) remains well-poised for growth on the resumption of elective surgeries, a diversified treatment network and solid cash reserves.

UnitedHealth Group (UNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UnitedHealth's (UNH) Suffering Continues: Should You Hold Tight?

by Zacks Equity Research

Each sub-segment of Optum, UnitedHealth's (UNH) health service business, is expected to continue delivering a solid performance, driving the overall segment's growth.

UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed at $477.88 in the latest trading session, marking a -0.57% move from the prior day.

Derek Lewis headshot

These 3 Companies Are Cash-Generating Machines

by Derek Lewis

A company displaying free cash flow strength has freedom for growth opportunities, can consistently shell out dividends, and wipe out debt easily.

UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed the most recent trading day at $482.56, moving +0.73% from the previous trading session.

Factors That Make HCA Healthcare (HCA) a Lucrative Bet Now

by Zacks Equity Research

HCA Healthcare (HCA) remains well-poised for growth on the resumption of elective surgeries, acquisitions and strong cash-generation abilities.

UnitedHealth Group (UNH) Expands Home Healthcare Business

by Zacks Equity Research

UnitedHealth Group (UNH) boosts home healthcare presence with the acquisition of Amedisys for $3.3 billion

UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

UnitedHealth's (UNH) Optum Rx Makes Patient Care Affordable

by Zacks Equity Research

UnitedHealth Group, Inc's. (UNH) Optum Rx is set to offer three biosimilar alternatives for HUMIRA effective Jul 1, providing affordability in patient care.

UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, UnitedHealth Group (UNH) closed at $476.75, marking a +1.57% move from the previous day.

UnitedHealth's (UNH) Program to Aid Georgia's Diabetic Patients

by Zacks Equity Research

UnitedHealth's (UNH) unit, UnitedHealthcare, extends its community-based program to improve the health conditions of Southwest Georgia's diabetic patients.

Kaibalya Pravo Dey headshot

U.S. Health Insurers Are Tumbling: Should You be Worried?

by Kaibalya Pravo Dey

Demand for procedures like hip and knee surgeries is rising, which will leave fewer premiums in hand after paying for the procedures for the health insurers.

Humana (HUM) Sees Insurance Costs at Upper Limit of Guidance

by Zacks Equity Research

Despite the rising demand for elective procedures, Humana (HUM) sticks to its earnings guidance.

UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

UnitedHealth (UNH) Falls 6.4% on Cost Woes of Resumed Surgeries

by Zacks Equity Research

UnitedHealth's (UNH) Optum Health unit is likely to witness higher utilization, especially in ambulatory surgery operations.